OpenVSafe by OpenVAERS
Search V-safe

EE6-14749-50049

3 vaccinations 6 coded responses 40 check-ins 6 free-text entries 1 call case
Sex
Female
Age at first dose
31-35
ZIP prefix
837 / ID
Registered
2021-03-07
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-07
    Registered in v-safe
  2. 2021-03-07
    Dose 1 — Pfizer-BioNTech
  3. 2021-03-07
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Pain · Headache, Nausea
    Adult check-in
  4. 2021-03-08
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain, Swelling · None
    Adult check-in
  5. 2021-03-09
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-03-10
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-03-11
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-03-12
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  9. 2021-03-13
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Fatigue or tiredness
    Adult check-in
  10. 2021-03-14
    Health check-in — day 7, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  11. 2021-03-21
    Health check-in — day 14, dose 1
    Feeling: Fair
    Adult check-in
  12. 2021-03-28
    Dose 2 — Pfizer-BioNTech
  13. 2021-03-28
    Health check-in — day 0, dose 2
    Feeling: Fair · Site: Pain · Fever · Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain
    Adult check-in
  14. 2021-03-29
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  15. 2021-03-30
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activities
    Adult check-in
  16. 2021-03-31
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Nausea, Diarrhea, Abdominal pain · Be unable to do your normal daily activities
    Adult check-in
  17. 2021-04-01
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Fatigue or tiredness, Nausea, Diarrhea · Be unable to do your normal daily activities
    Adult check-in
  18. 2021-04-02
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-04-03
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  20. 2021-04-04
    Health check-in — day 7, dose 2
    Feeling: Good · Nausea
    Adult check-in
  21. 2021-04-11
    Health check-in — day 14, dose 2
    Feeling: Fair
    Adult check-in
  22. 2021-04-18
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-04-25
    Health check-in — day 28, dose 2
    Feeling: Fair
    Adult check-in
  24. 2021-05-03
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-05-09
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-06-28
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-09-26
    Health check-in — 6 months, dose 2
    Feeling: Fair
    Adult check-in
  28. 2021-10-02
    Dose 3 — Pfizer-BioNTech
  29. 2021-10-02
    Health check-in — day 0, dose 3
    Feeling: Fair · Site: Pain, Swelling · Fatigue or tiredness
    Adult check-in
  30. 2021-10-03
    Survey response — days 1–6 daily, dose 3
    MedDRA: Chest pain — Feeling: Poor · Site: Pain, Swelling · Fever · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Free text: Chest pain
    MedDRA releases: 2024-11 · check-in free text available
  31. 2021-10-04
    Survey response — days 1–6 daily, dose 3
    MedDRA: Chest pain — Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea
    Free text: Chest pain
    MedDRA releases: 2024-11 · check-in free text available
  32. 2021-10-05
    Survey response — days 1–6 daily, dose 3
    MedDRA: Chest pain — Feeling: Fair · Fatigue or tiredness, Nausea
    Free text: Chest pain
    MedDRA releases: 2024-11 · check-in free text available
  33. 2021-10-06
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Fatigue or tiredness
    Adult check-in
  34. 2021-10-07
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  35. 2021-10-08
    Survey response — days 1–6 daily, dose 3
    MedDRA: Chest pain — Feeling: Good · Fatigue or tiredness
    Free text: Chest pain
    MedDRA releases: 2024-11 · check-in free text available
  36. 2021-10-09
    Survey response — day 7, dose 3
    MedDRA: Chest pain — Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Chest pain
    MedDRA releases: 2024-11 · check-in free text available
  37. 2021-10-16
    Health check-in — day 14, dose 3
    Feeling: Fair
    Adult check-in
  38. 2021-10-23
    Health check-in — day 21, dose 3
    Feeling: Fair
    Adult check-in
  39. 2021-10-30
    Health check-in — day 28, dose 3
    Feeling: Fair
    Adult check-in
  40. 2021-11-06
    Health check-in — day 35, dose 3
    Feeling: Fair
    Adult check-in
  41. 2021-11-13
    Health check-in — day 42, dose 3
    Feeling: Fair
    Adult check-in
  42. 2022-01-01
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  43. 2022-04-02
    Health check-in — 6 months, dose 3
    Feeling: Poor
    Adult check-in
  44. 2022-10-08
    Survey response — 12 months, dose 3
    MedDRA: Gestational diabetes — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Gestational Diabetes
    MedDRA releases: 2024-11 · check-in free text available
  45. 2022-10-08
    Report sent to call center — 12 months, dose 3
    Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  46. 2022-10-10

Vaccinations

DoseDateManufacturerCo-administered
12021-03-07Pfizer-BioNTech
22021-03-28Pfizer-BioNTech
32021-10-02Pfizer-BioNTech No

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 9 — days 1–6 daily, dose 3

2021-10-03

Systemic reaction (other): Chest pain

Release 10 — days 1–6 daily, dose 3

2021-10-04

Systemic reaction (other): Chest pain

2021-10-05

Systemic reaction (other): Chest pain

2021-10-08

Systemic reaction (other): Chest pain

Release 10 — day 7, dose 3

2021-10-09

Systemic reaction (other): Chest pain

Release 12 — 12 months, dose 3

2022-10-08

Symptoms: Gestational Diabetes

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDGestational diabetes · · ✓
SROChest pain · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release